Anatoly V. Kubyshkin

758 total citations
67 papers, 379 citations indexed

About

Anatoly V. Kubyshkin is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Anatoly V. Kubyshkin has authored 67 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Anatoly V. Kubyshkin's work include Neurological Disorders and Treatments (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Phytochemicals and Antioxidant Activities (6 papers). Anatoly V. Kubyshkin is often cited by papers focused on Neurological Disorders and Treatments (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Phytochemicals and Antioxidant Activities (6 papers). Anatoly V. Kubyshkin collaborates with scholars based in Russia, Ukraine and United States. Anatoly V. Kubyshkin's co-authors include И. И. Фомочкина, Volodymyr V. Oberemok, Kateryna V. Laikova, Ilya Novikov, Nikita V. Gal’chinsky, Vadim Kumeiko, N. V. Lomakin, Armen Petrosyan, Walery Żukow and Chad A. LaGrange and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anatoly V. Kubyshkin

48 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anatoly V. Kubyshkin Russia 10 122 68 43 32 32 67 379
И. И. Фомочкина Russia 9 99 0.8× 49 0.7× 34 0.8× 30 0.9× 30 0.9× 36 290
Zhen Zhu China 13 190 1.6× 42 0.6× 60 1.4× 28 0.9× 46 1.4× 39 413
Leihong Xiang China 14 157 1.3× 102 1.5× 28 0.7× 11 0.3× 19 0.6× 40 740
Arun Balasubramaniam United States 11 172 1.4× 57 0.8× 31 0.7× 12 0.4× 15 0.5× 20 414
Meysam Soleimani Iran 14 266 2.2× 97 1.4× 57 1.3× 75 2.3× 15 0.5× 41 551
Xinglong Liu China 15 147 1.2× 34 0.5× 79 1.8× 66 2.1× 15 0.5× 43 465
Béatrice Bertino France 12 169 1.4× 90 1.3× 18 0.4× 41 1.3× 12 0.4× 15 618
Hao Ran China 11 104 0.9× 67 1.0× 32 0.7× 19 0.6× 21 0.7× 45 494
Jingjing Wei China 14 275 2.3× 63 0.9× 28 0.7× 29 0.9× 12 0.4× 38 573
Yuan Ding China 15 263 2.2× 109 1.6× 45 1.0× 20 0.6× 54 1.7× 51 633

Countries citing papers authored by Anatoly V. Kubyshkin

Since Specialization
Citations

This map shows the geographic impact of Anatoly V. Kubyshkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anatoly V. Kubyshkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anatoly V. Kubyshkin more than expected).

Fields of papers citing papers by Anatoly V. Kubyshkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anatoly V. Kubyshkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anatoly V. Kubyshkin. The network helps show where Anatoly V. Kubyshkin may publish in the future.

Co-authorship network of co-authors of Anatoly V. Kubyshkin

This figure shows the co-authorship network connecting the top 25 collaborators of Anatoly V. Kubyshkin. A scholar is included among the top collaborators of Anatoly V. Kubyshkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anatoly V. Kubyshkin. Anatoly V. Kubyshkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubyshkin, Anatoly V., et al.. (2024). SARS-CoV-2 and the thyroid gland – an experimental study of cell and tissue responses. Medical news of the North Caucasus. 19(3).
2.
Плоскирева, А.А., et al.. (2024). Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers. Annals of the Russian academy of medical sciences. 79(1). 42–51.
3.
Morris, Mary E., Chad A. LaGrange, Anatoly V. Kubyshkin, et al.. (2023). Targeting the ATF6-Mediated ER Stress Response and Autophagy Blocks Integrin-Driven Prostate Cancer Progression. Molecular Cancer Research. 21(9). 958–974. 7 indexed citations
4.
Oberemok, Volodymyr V., et al.. (2023). Adjuvant Oligonucleotide Vaccine Increases Survival and Improves Lung Tissue Condition of B6.Cg-Tg (K18-ACE2)2 Transgenic Mice. Scientia Pharmaceutica. 91(3). 35–35. 2 indexed citations
5.
Kubyshkin, Anatoly V., et al.. (2023). Molecular genetic testing in ovarian cancer. Pacific Medical Journal. 11–18.
6.
Kubyshkin, Anatoly V., et al.. (2022). Influence of antibiotic therapy on indicators of endotoxinemia and systemic inflammation in acute SARS-CoV-2 lung damage. SHILAP Revista de lepidopterología. 7(1). 12–18.
7.
Kubyshkin, Anatoly V., et al.. (2022). Lipopolysaccharide-binding protein and presepsin in patients with SARS-CoV-2 viral lung disease in the Republic of Crimea. PULMONOLOGIYA. 32(2). 162–170. 2 indexed citations
8.
Oberemok, Volodymyr V., et al.. (2021). Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α Expression. International Journal of Molecular Sciences. 22(3). 1022–1022. 8 indexed citations
9.
Kubyshkin, Anatoly V., et al.. (2021). The role of dysmetabolic mechanisms in the development of neurodegenerative processes in an experimental metabolic-cognitive syndrome model. Medical news of the North Caucasus. 16(2). 1 indexed citations
10.
Kubyshkin, Anatoly V., et al.. (2020). Optogenetic methods and technologies in solving applied medical problems. SHILAP Revista de lepidopterología. 19(2). 195–203. 1 indexed citations
11.
Laikova, Kateryna V., Volodymyr V. Oberemok, Nikita V. Gal’chinsky, et al.. (2019). Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules. 24(8). 1516–1516. 78 indexed citations
12.
Kubyshkin, Anatoly V., et al.. (2019). Immunophenotype of the macrophage population in fibrous, cavernous pulmonary tuberculosis. SHILAP Revista de lepidopterología. 18(1). 190–200. 1 indexed citations
13.
Oberemok, Volodymyr V., Kateryna V. Laikova, Nikita V. Gal’chinsky, et al.. (2019). DNA insecticide developed from the Lymantria dispar 5.8S ribosomal RNA gene provides a novel biotechnology for plant protection. Scientific Reports. 9(1). 6197–6197. 21 indexed citations
15.
Kubyshkin, Anatoly V., et al.. (2018). Media and the Cold War: a comparative perspective. Mediaobrazovanie. 1 indexed citations
16.
17.
Kubyshkin, Anatoly V., et al.. (2017). Expression of caspase-3 and the cytokine level in experimental reperfusion syndrome upon treatment with peroxiredoxin 6. BIOPHYSICS. 62(5). 848–852. 1 indexed citations
18.
Kubyshkin, Anatoly V., et al.. (2017). Proinflammatory cytokines changes in clinical course of acute myocardial infarction. Bulletin of Siberian Medicine. 16(1). 92–100. 7 indexed citations
19.
Kubyshkin, Anatoly V., et al.. (2016). CARDIOPROTECTIVE EFFECT OF NATIVE ANTIHYPOXANTS IN EXPERIMENTAL COBALT CARDIOMYOPATHY. Bulletin of Siberian Medicine. 15(3). 33–40. 2 indexed citations
20.
Birkun, Alexei, et al.. (2014). Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas -Induced Pneumonia. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(4). 299–307. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026